RBBP9 antibody
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
RBBP9 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab07154
tested applications
ELISA, WB, IHC, IP
Description
May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | retinoblastoma binding protein 9 (RBBP9) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | WB: 1:500-1:5000; IP:1:200-1:1000; IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 22 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, WB, IHC, IP |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | O75884 |
| Gene ID | 10741 |
| Alias | Serine hydrolase RBBP9,B5T-overexpressed gene protein (Protein BOG),Retinoblastoma-binding protein 10 (RBBP-10),Retinoblastoma-binding protein 9 (RBBP-9),RBBP9,BOG,RBBP10 |
| Background | Antibody anti-RBBP9 |
| Status | RUO |
| Note | Mol. Weight 22 kDa |
Descripción
Related Products
RBBP9 antibody
May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.
Ver ProductoRBBP9 antibody
May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.
Ver ProductoRBBP9 antibody
May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.
Ver Producto